Nanoparticle-formulated siRNA targeting integrins inhibits hepatocellular carcinoma progression in mice.
about
β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of CancerNanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinomaScreening of efficient siRNA carriers in a library of surface-engineered dendrimersLoss of α-catenin elicits a cholestatic response and impairs liver regeneration.Ionizable amphiphilic dendrimer-based nanomaterials with alkyl-chain-substituted amines for tunable siRNA delivery to the liver endothelium in vivoStructural and functional hepatocyte polarity and liver disease.Combination of Nanoparticle-Delivered siRNA for Astrocyte Elevated Gene-1 (AEG-1) and All-trans Retinoic Acid (ATRA): An Effective Therapeutic Strategy for Hepatocellular Carcinoma (HCC).Iron-Oxide-Based Nanovector for Tumor Targeted siRNA Delivery in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse ModelPolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery.Polyphosphoester nanoparticles as biodegradable platform for delivery of multiple drugs and siRNA.RNAi-nanoparticulate manipulation of gene expression as a new functional genomics tool in the liver.Strategies to optimize siRNA delivery to hepatocellular carcinoma cells.Delivery strategies and potential targets for siRNA in major cancer typesThe immune system in hepatocellular carcinoma and potential new immunotherapeutic strategies.Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma.Inhibitory Effects of PEI-RGD/125I-(αv) ASODN on Growth and Invasion of HepG2 Cells.Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration.Cationic fluorescent polymer core-shell nanoparticles for encapsulation, delivery, and non-invasively tracking the intracellular release of siRNA.β1 integrin-mediated multicellular resistance in hepatocellular carcinoma through activation of the FAK/Akt pathway.A flexible microneedle array as low-voltage electroporation electrodes for in vivo DNA and siRNA delivery.Preparation and Optimization of Lipid-Like Nanoparticles for mRNA Delivery.
P2860
Q26774789-1CBC1BDD-2740-4B7F-BE5B-7AC9A4A5790BQ26823523-93BB694B-DEC4-4403-9A85-D3DD85B97DA1Q28834046-B2C5DBAC-26C6-461E-90C2-0C9111F69290Q34424374-B5B04625-60CB-49AA-927F-1FD9EEC7896FQ35374908-3DA92B6F-917C-42EC-98F2-3CF5BC3592F5Q36090717-A7149D9E-6A74-43BD-8234-B508F8989AB8Q36664787-8E060A5C-C322-4093-A612-1002C872713DQ36792563-4327F79F-4662-4F58-8FCB-DA19EFDD4B04Q36980520-71A30F43-0BA0-45F4-AAD2-C2F4606A45F2Q37669173-616A9236-550F-4FAB-B679-3E3AB1F10BA4Q37738253-B9BDE53C-5DC4-467B-97D4-492059260A63Q38713376-5C50920A-2E0C-450F-909D-516F4B283684Q38853191-7BEF16F0-B41A-4A84-9D29-F5886AEDC26DQ39535683-BA6D17A4-BC31-4227-AAE8-58D008E941F6Q42434482-34A8E6FD-C40A-4B75-B7E0-D2A770FED2F9Q42532649-663B9E28-85B6-4010-AB6B-83B4EB27560AQ47829403-72EFCE8C-AF5E-4349-86F7-3C25B11FA590Q48687614-1EAC967B-FF1E-4B01-9431-05DDB8E1EA39Q50052675-FDCCC8DF-0080-45B4-8F1D-983A4C546791Q51509343-62268AAD-C549-4D2E-BE94-30B050B85947Q52761615-8E8FB9F4-D8A5-4CDE-ABB7-306ADD133ACE
P2860
Nanoparticle-formulated siRNA targeting integrins inhibits hepatocellular carcinoma progression in mice.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Nanoparticle-formulated siRNA ...... carcinoma progression in mice.
@en
type
label
Nanoparticle-formulated siRNA ...... carcinoma progression in mice.
@en
prefLabel
Nanoparticle-formulated siRNA ...... carcinoma progression in mice.
@en
P2093
P2860
P50
P356
P1476
Nanoparticle-formulated siRNA ...... carcinoma progression in mice
@en
P2093
Daniel G Anderson
Hidenori Nonaka
Marino Zerial
Roman L Bogorad
P2860
P2888
P356
10.1038/NCOMMS4869
P407
P577
2014-05-21T00:00:00Z